Get Premium to unlock powerful stock data
NYSE:DNA (USA)  
Ginkgo Bioworks Holdings Inc logo

Ginkgo Bioworks Holdings Inc

$ 2.38 0 (0%) 08:08 PM EST
P/E:
At Loss
P/B:
2.44
Market Cap:
$ 4.23B
Enterprise V:
$ 2.76B
Volume:
15.67M
Avg Vol (2M):
25.32M
Volume:
15.67M
Market Cap $:
4.23B
PE Ratio:
At Loss
Avg Vol (2-Month):
25.32M
Enterprise Value $:
2.76B
PB Ratio:
2.44
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Ginkgo Bioworks Holdings Inc
NAICS : 541714 SIC : 2836
27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210
Description
Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals.
Name Current Vs Industry Vs History
Cash-To-Debt 54.67
Equity-to-Asset 0.77
Debt-to-Equity 0.02
Debt-to-EBITDA -0.01
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.06
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator

Growth Rank

Name Current Vs Industry Vs History
Future 3-5Y Total Revenue Growth Rate Industry Rank 25.38

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 30.82
9-Day RSI 38.21
14-Day RSI 41.42
6-1 Month Momentum % -64.14

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.71
Quick Ratio 10.66
Cash Ratio 9.38
Days Inventory 10.84
Days Sales Outstanding 110.39
Days Payable 35.28

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-08-31 Est.)

DNA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NYSE:DNA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 394.509
EPS (TTM) ($) -1.55
Beta 0
Volatility % 0
14-Day RSI 41.42
14-Day ATR ($) 0.296103
20-Day SMA ($) 2.785
12-1 Month Momentum % 0
52-Week Range ($) 2.09 - 15.864
Shares Outstanding (Mil) 1,776.64

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Ginkgo Bioworks Holdings Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More